Prosecution Insights
Last updated: August 18, 2026

Examiner: GOUGH, TIFFANY MAUREEN

Tech Center 1600 • Art Units: 1651 1657

This examiner grants 31% of resolved cases

Performance Statistics

31.4%
Allow Rate
-28.6% vs TC avg
556
Total Applications
+46.9%
Interview Lift
1655
Avg Prosecution Days
Based on 519 resolved cases, 2023–2026

Rejection Statute Breakdown

5.4%
§101 Eligibility
17.2%
§102 Novelty
39.6%
§103 Obviousness
22.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18260914 A METHOD TO IDENTIFY LVAD PATIENTS WITH ELEVATED LEVELS OF BLOOD ACTIVATION USING COUPON TESTS Final Rejection Boston Scientific Scimed, Inc.
19416925 AMYLASE COMPOSITIONS FOR PRODUCING COLLAGEN PEPTIDES AND METHODS OF FORMING COLLAGEN PEPTIDES Non-Final OA Rochal Technologies, LLC
18478096 Biological Indicator with Enhanced Volatile Organic Compound Detection Non-Final OA O&M Halyard, Inc.
17758585 Self-Contained Biological Indicator with Salt Compound Non-Final OA Solventum Intellectual Properties Company
18081147 EVALUATION SYSTEM AND EVALUATION METHOD Final Rejection Hitachi, Ltd.
18220864 COMBINATION THERAPEUTICS USING TUMOR TREATING FIELDS (TTFIELDS) Final Rejection THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
18695099 METHOD FOR CULTURING MICROORGANISM, TRANSFORMED MICROORGANISM, AND METHOD FOR PRODUCING POLY(3-HYDROXYALKANOATE) Non-Final OA KANEKA CORPORATION
18863096 PEST CONTROL COMPOSITIONS Non-Final OA Rohm and Haas Company
18285088 PROCESS FOR BIOCONJUGATE PRODUCTION Non-Final OA GLAXOSMITHKLINE BIOLOGICALS S.A.
17789045 LACTIC ACID BACTERIUM FERMENTATION PROMOTER Non-Final OA MEIJI CO., LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month